Profil
Florian von der Muelbe is the founder of CureVac SE and CureVac NV, both founded in 2000.
He holds the title of Chief Production Officer at CureVac SE from 2018 to present.
He also held the title of Chief Production Officer at CureVac NV from 2015 to 2021.
Dr. von der Muelbe is currently a Co-Managing Director at CureVac Real Estate GmbH since 2017.
He previously worked as a Principal at Biotest AG.
Dr. von der Muelbe holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from ESB Business School.
Postes actifs de Florian von der Muelbe
| Sociétés | Poste | Début |
|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Fondateur | 01/01/2000 |
CureVac Real Estate GmbH
CureVac Real Estate GmbH Real Estate DevelopmentFinance Manages commercial and non-residential buildings | Directeur Général | 01/02/2017 |
Anciens postes connus de Florian von der Muelbe
| Sociétés | Poste | Fin |
|---|---|---|
| CUREVAC | Fondateur | 01/07/2021 |
| BIOTEST GMBH & CO. KGAA | Corporate Officer/Principal | - |
Formation de Florian von der Muelbe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Biotest AG
Biotest AG Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes therapy medicinal products | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESB Business School
ESB Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureVac Real Estate GmbH
CureVac Real Estate GmbH Real Estate DevelopmentFinance Manages commercial and non-residential buildings | Finance |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
















